Invariant natural killer T cells have emerged as a potentially versatile allogeneic platform for blood cancer immunotherapy, ...

Janos L. Tanyi, MD, PhD, of Penn Medicine, shared an early report of a new type of CAR T cell therapy, called KIR-CAR, in a Clinical Trial Plenary session at the AACR Annual Meeting 2026.

Cancer cells have been shown to have the ability to use lipids to evade attack by immune cells, and a new study in mice has found that fasting trains immune system cells to be more resistant to lipids ...

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with the potential to overcome key limitations of current chimeric antigen ...

株式会社グローバルインフォメーションは、市場調査レポート「ナチュラルキラー細胞治療薬市場：世界の業界動向、シェア、規模、成長、機会、予測（2021年～2026年）」（IMARC Services Private Limited）の販売を3月28日より開始いたしました。 世界のナチュラル ...

Myocardial infarction research reveals immune-driven cardiac damage. Learn how targeting NK cells could improve heart ...

Natural killer cells, or NK cells, are elements of the immune system capable of rapidly locating and destroying cancerous or infected cells. Their use in therapy, particularly by equipping them with ...

2022年7月14日に、QYResearchは「グローバルナチュラルキラー細胞療法に関する市場レポート, 2017年-2028年の推移と予測、会社別、地域別、製品別、アプリケーション別の情報」の調査資料を発表しました。ナチュラルキラー細胞療法トの市場生産能力、生産量 ...